First AI-Powered ALS Educational Platform Launches for the Public
April 20, 2022 11:30 ET
|
StoryFile
Los Angeles, CA, April 20, 2022 (GLOBE NEWSWIRE) -- StoryFile, an AI startup redefining the media landscape through its proprietary storytelling technology, announced the launch of its first...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important April 29 Deadline in Securities Class Action – CABA
April 19, 2022 17:15 ET
|
The Rosen Law Firm PA
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or...
AXIM Biotech Develops Rapid Quantitative Tear Test for MMP-9, An Inflammatory Biomarker of Dry Eye Disease
March 08, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting dry eye...
Worldwide Diagnostic Biomarkers Market Size to Reach $95.1 Billion by 2028 - Use of Biomarkers to Give Accurate and Consistent Results Over Conventional Diagnostic Tools Drives the Market – Vantage Market Research
February 22, 2022 08:46 ET
|
Vantage Market Research
WASHINGTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Diagnostic Biomarkers Market finds that because of huge advancement in diagnostic tools, they...
AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch
February 15, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
AXIM is driven to positively transform the state of Dry Eye Disease (DED) testing and diagnosis The company will deploy industry leader IUL’s state-of-the-art iPeak readers Company Adds Veteran Lab...
EDENLUX Launches Campaign for Otus, the Personal EYE-Trainer
November 17, 2021 00:00 ET
|
EDENLUX
CYPRESS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Otus, created by EDENLUX, has launched a campaign through Indiegogo. Otus is a personal eye-trainer that is made for the purpose of training...
InvestorBrandNetwork Announces The Dealmaker Show Interview with Tryp Therapeutics Inc. CEO Greg McKee
August 03, 2021 08:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
Aegis Sciences Announces CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19
March 16, 2021 09:00 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn., March 16, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services,...
AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th
March 11, 2021 07:00 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be...
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
February 24, 2021 10:00 ET
|
Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...